FDA Inspection
B. Braun Medical IncB. Braun Medical Inc – FDA Inspection, Aug 17, 2021
Record Details
This FDA Inspection record concerns B. Braun Medical Inc, with an inspection on August 17, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- B. Braun Medical Inc
- Inspection Date
- August 17, 2021
- Product Type
- Drugs
View Company Profile
ID · fcaa1042-0ff0-4bfb-a0e3-39817a40ae9b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1152417
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of B. Braun Medical Inc
14| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | OAI | Los Angeles District Office | Drug Quality Assurance |
| August 6, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2023 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| June 29, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for B. Braun Medical Inc
- FDA Inspection 1292536 - 2025-11-21
- FDA Inspection 1231010 - 2024-08-06
- FDA Inspection 1226163 - 2023-12-15
- FDA Inspection 1222593 - 2023-10-13
- FDA Inspection 1057639 - 2018-06-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.